Laboratory of Physiological Chemistry, Institute of Medicinal Chemistry, Hoshi University, Shinagawa, Tokyo 142-8501, Japan.
Laboratory of Physiological Chemistry, Institute of Medicinal Chemistry, Hoshi University, Shinagawa, Tokyo 142-8501, Japan.
Pharmacol Ther. 2022 Feb;230:107942. doi: 10.1016/j.pharmthera.2021.107942. Epub 2021 Jun 24.
Vitamin A is an important micro-essential nutrient, whose primary dietary source is retinyl esters. In addition, β-carotene (pro-vitamin A) is a precursor of vitamin A contained in green and yellow vegetables that is converted to retinol in the body after ingestion. Retinol is oxidized to produce visual retinal, which is further oxidized to retinoic acid (RA), which is used as a therapeutic agent for patients with promyelocytic leukemia. Thus, the effects of retinal and RA are well known. In this paper, we will introduce (1) vitamin A circulation in the body, (2) the actions and mechanisms of retinal and RA, (3) retinoylation: another RA mechanism not depending on RA receptors, (4) the relationship between cancer and actions of retinol or β-carotene, whose roles in vivo are still unknown, and (5) anti-cancer actions of vitamin A derivatives derived from fenretinide (4-HPR). We propose that vitamin A nutritional management is effective in the prevention of cancer.
维生素 A 是一种重要的微量必需营养素,其主要膳食来源是视黄酯。此外,β-胡萝卜素(维生素 A 前体)是一种存在于绿色和黄色蔬菜中的维生素 A 前体,在摄入后会在体内转化为视黄醇。视黄醇被氧化生成视觉视网膜,进一步氧化生成视黄酸(RA),视黄酸可作为早幼粒细胞白血病患者的治疗剂。因此,视网膜和 RA 的作用是众所周知的。在本文中,我们将介绍(1)体内维生素 A 的循环,(2)视网膜和 RA 的作用和机制,(3)视黄酰化:另一种不依赖 RA 受体的 RA 机制,(4)视黄醇或β-胡萝卜素与癌症之间的关系,其在体内的作用仍不清楚,以及(5)来源于芬维 A 酯(4-HPR)的维生素 A 衍生物的抗癌作用。我们提出,维生素 A 的营养管理可有效预防癌症。